Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor

R. K. Pearson, Laurence J Miller

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Previous biochemical characterizations of the cholecystokinin (CCK) receptor have used the 'long' probe 125I-Bolton-Hunter-CCK-33 since it was the only CCK analogue with high affinity and high specific radioactivity which possessed an amino group available for chemical cross-linking. These studies have consistently identified a major binding protein of approximately 81 kilodaltons and have identified several minor proteins which were obtained under different cross-linking conditions and in different laboratories. Because the receptor-binding region of CCK-33 (carboxyl-terminal heptapeptide) is so far removed from the radiolabel and from available amino groups (positions 1 and 11), this probe carries potential for proteolytic cleavage of label from receptor and for labeling 'near neighbors' instead of the binding site. We therefore designed two 'short' probes for the CCK receptor. 125I-Bolton-Hunter-Lys-Gly-CCK-8 has an ε-amino group available for cross-linking. 125I-Tyr-[Thr28,Nle31]CCK-25-33 has an α-amino group for cross-linking and has the major advantage of being labeled by oxidative means, unique for CCK derivatives. Both radioiodinated decapeptides were purified by reverse-phase high pressure liquid chromatography to yield specific radioactivity of 2,000 Ci/mmol; demonstrated saturable, specific, and high affinity binding to rat pancreatic plasma membranes; and retained full biological activity to stimulate amylase secretion. Using a variety of cross-linking methods, these probes each identified the same M(r) = 85,000-95,000 protein in rat pancreatic plasmalemma, and CCK-8 competed for this labeling in a concentration-dependent manner (IC50 = 1 nM). No change in apparent mobility of this band was observed under reducing or nonreducing conditions, suggesting lack of covalent attachment to other subunits. The M(r) = 85,000-95,000 species migrated differently on sodium dodecyl sulfate gels than any of the components previously identified using 125I-Bolton-Hunter-CCK-33, confirming the novel nature of this binding protein. These short probes should be very useful for further characterization of CCK receptor on this and other tissues.

Original languageEnglish (US)
Pages (from-to)869-876
Number of pages8
JournalJournal of Biological Chemistry
Volume262
Issue number2
StatePublished - 1987

Fingerprint

Cholecystokinin
Labeling
Rats
Carrier Proteins
Cholecystokinin Receptors
Radioactivity
High pressure liquid chromatography
Cell membranes
Amylases
Bioactivity
Sodium Dodecyl Sulfate
Reverse-Phase Chromatography
Labels
Proteins
Inhibitory Concentration 50
Gels
Binding Sites
Tissue
Derivatives
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{45716f50302d4bf7a583ab0304aac908,
title = "Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor",
abstract = "Previous biochemical characterizations of the cholecystokinin (CCK) receptor have used the 'long' probe 125I-Bolton-Hunter-CCK-33 since it was the only CCK analogue with high affinity and high specific radioactivity which possessed an amino group available for chemical cross-linking. These studies have consistently identified a major binding protein of approximately 81 kilodaltons and have identified several minor proteins which were obtained under different cross-linking conditions and in different laboratories. Because the receptor-binding region of CCK-33 (carboxyl-terminal heptapeptide) is so far removed from the radiolabel and from available amino groups (positions 1 and 11), this probe carries potential for proteolytic cleavage of label from receptor and for labeling 'near neighbors' instead of the binding site. We therefore designed two 'short' probes for the CCK receptor. 125I-Bolton-Hunter-Lys-Gly-CCK-8 has an ε-amino group available for cross-linking. 125I-Tyr-[Thr28,Nle31]CCK-25-33 has an α-amino group for cross-linking and has the major advantage of being labeled by oxidative means, unique for CCK derivatives. Both radioiodinated decapeptides were purified by reverse-phase high pressure liquid chromatography to yield specific radioactivity of 2,000 Ci/mmol; demonstrated saturable, specific, and high affinity binding to rat pancreatic plasma membranes; and retained full biological activity to stimulate amylase secretion. Using a variety of cross-linking methods, these probes each identified the same M(r) = 85,000-95,000 protein in rat pancreatic plasmalemma, and CCK-8 competed for this labeling in a concentration-dependent manner (IC50 = 1 nM). No change in apparent mobility of this band was observed under reducing or nonreducing conditions, suggesting lack of covalent attachment to other subunits. The M(r) = 85,000-95,000 species migrated differently on sodium dodecyl sulfate gels than any of the components previously identified using 125I-Bolton-Hunter-CCK-33, confirming the novel nature of this binding protein. These short probes should be very useful for further characterization of CCK receptor on this and other tissues.",
author = "Pearson, {R. K.} and Miller, {Laurence J}",
year = "1987",
language = "English (US)",
volume = "262",
pages = "869--876",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor

AU - Pearson, R. K.

AU - Miller, Laurence J

PY - 1987

Y1 - 1987

N2 - Previous biochemical characterizations of the cholecystokinin (CCK) receptor have used the 'long' probe 125I-Bolton-Hunter-CCK-33 since it was the only CCK analogue with high affinity and high specific radioactivity which possessed an amino group available for chemical cross-linking. These studies have consistently identified a major binding protein of approximately 81 kilodaltons and have identified several minor proteins which were obtained under different cross-linking conditions and in different laboratories. Because the receptor-binding region of CCK-33 (carboxyl-terminal heptapeptide) is so far removed from the radiolabel and from available amino groups (positions 1 and 11), this probe carries potential for proteolytic cleavage of label from receptor and for labeling 'near neighbors' instead of the binding site. We therefore designed two 'short' probes for the CCK receptor. 125I-Bolton-Hunter-Lys-Gly-CCK-8 has an ε-amino group available for cross-linking. 125I-Tyr-[Thr28,Nle31]CCK-25-33 has an α-amino group for cross-linking and has the major advantage of being labeled by oxidative means, unique for CCK derivatives. Both radioiodinated decapeptides were purified by reverse-phase high pressure liquid chromatography to yield specific radioactivity of 2,000 Ci/mmol; demonstrated saturable, specific, and high affinity binding to rat pancreatic plasma membranes; and retained full biological activity to stimulate amylase secretion. Using a variety of cross-linking methods, these probes each identified the same M(r) = 85,000-95,000 protein in rat pancreatic plasmalemma, and CCK-8 competed for this labeling in a concentration-dependent manner (IC50 = 1 nM). No change in apparent mobility of this band was observed under reducing or nonreducing conditions, suggesting lack of covalent attachment to other subunits. The M(r) = 85,000-95,000 species migrated differently on sodium dodecyl sulfate gels than any of the components previously identified using 125I-Bolton-Hunter-CCK-33, confirming the novel nature of this binding protein. These short probes should be very useful for further characterization of CCK receptor on this and other tissues.

AB - Previous biochemical characterizations of the cholecystokinin (CCK) receptor have used the 'long' probe 125I-Bolton-Hunter-CCK-33 since it was the only CCK analogue with high affinity and high specific radioactivity which possessed an amino group available for chemical cross-linking. These studies have consistently identified a major binding protein of approximately 81 kilodaltons and have identified several minor proteins which were obtained under different cross-linking conditions and in different laboratories. Because the receptor-binding region of CCK-33 (carboxyl-terminal heptapeptide) is so far removed from the radiolabel and from available amino groups (positions 1 and 11), this probe carries potential for proteolytic cleavage of label from receptor and for labeling 'near neighbors' instead of the binding site. We therefore designed two 'short' probes for the CCK receptor. 125I-Bolton-Hunter-Lys-Gly-CCK-8 has an ε-amino group available for cross-linking. 125I-Tyr-[Thr28,Nle31]CCK-25-33 has an α-amino group for cross-linking and has the major advantage of being labeled by oxidative means, unique for CCK derivatives. Both radioiodinated decapeptides were purified by reverse-phase high pressure liquid chromatography to yield specific radioactivity of 2,000 Ci/mmol; demonstrated saturable, specific, and high affinity binding to rat pancreatic plasma membranes; and retained full biological activity to stimulate amylase secretion. Using a variety of cross-linking methods, these probes each identified the same M(r) = 85,000-95,000 protein in rat pancreatic plasmalemma, and CCK-8 competed for this labeling in a concentration-dependent manner (IC50 = 1 nM). No change in apparent mobility of this band was observed under reducing or nonreducing conditions, suggesting lack of covalent attachment to other subunits. The M(r) = 85,000-95,000 species migrated differently on sodium dodecyl sulfate gels than any of the components previously identified using 125I-Bolton-Hunter-CCK-33, confirming the novel nature of this binding protein. These short probes should be very useful for further characterization of CCK receptor on this and other tissues.

UR - http://www.scopus.com/inward/record.url?scp=0023125680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023125680&partnerID=8YFLogxK

M3 - Article

VL - 262

SP - 869

EP - 876

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -